244 related articles for article (PubMed ID: 28536479)
1. Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic disease.
Heishima K; Ichikawa Y; Yoshida K; Iwasaki R; Sakai H; Nakagawa T; Tanaka Y; Hoshino Y; Okamura Y; Murakami M; Maruo K; Akao Y; Mori T
Sci Rep; 2017 May; 7(1):2301. PubMed ID: 28536479
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours.
Bulkowska M; Rybicka A; Senses KM; Ulewicz K; Witt K; Szymanska J; Taciak B; Klopfleisch R; Hellmén E; Dolka I; Gure AO; Mucha J; Mikow M; Gizinski S; Krol M
BMC Cancer; 2017 Nov; 17(1):728. PubMed ID: 29115935
[TBL] [Abstract][Full Text] [Related]
3. Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
Masuda T; Shinden Y; Noda M; Ueo H; Hu Q; Yoshikawa Y; Tsuruda Y; Kuroda Y; Ito S; Eguchi H; Ohno S; Mimori K
Anticancer Res; 2018 Aug; 38(8):4515-4523. PubMed ID: 30061217
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage.
Wang H; Peng R; Wang J; Qin Z; Xue L
Clin Epigenetics; 2018; 10():59. PubMed ID: 29713393
[TBL] [Abstract][Full Text] [Related]
5. Detection of novel polymorphisms in the ckit gene of canine patients with lymphoma, melanoma, haemangiosarcoma, and osteosarcoma.
Gramer I; Kessler M; Geyer J
Vet Res Commun; 2016 Jun; 40(2):89-95. PubMed ID: 26971271
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA as biomarkers of canine mammary carcinoma in dogs.
Fish EJ; Martinez-Romero EG; DeInnocentes P; Koehler JW; Prasad N; Smith AN; Bird RC
J Vet Intern Med; 2020 May; 34(3):1282-1290. PubMed ID: 32342546
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.
Hamam R; Hamam D; Alsaleh KA; Kassem M; Zaher W; Alfayez M; Aldahmash A; Alajez NM
Cell Death Dis; 2017 Sep; 8(9):e3045. PubMed ID: 28880270
[TBL] [Abstract][Full Text] [Related]
10. Association of tumour-infiltrating regulatory T cells with adverse outcomes in dogs with malignant tumours.
Sakai K; Maeda S; Yamada Y; Chambers JK; Uchida K; Nakayama H; Yonezawa T; Matsuki N
Vet Comp Oncol; 2018 Sep; 16(3):330-336. PubMed ID: 29322606
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer.
Aboutalebi H; Bahrami A; Soleimani A; Saeedi N; Rahmani F; Khazaei M; Fiuji H; Shafiee M; Ferns GA; Avan A; Hassanian SM
Int J Biochem Cell Biol; 2020 Jul; 124():105765. PubMed ID: 32428568
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs as biomarkers in cancer diagnosis.
Sohel MMH
Life Sci; 2020 May; 248():117473. PubMed ID: 32114007
[TBL] [Abstract][Full Text] [Related]
13. Morphology and immunophenotype of canine cutaneous histiocytic tumours with particular emphasis on diagnostic application.
Paździor-Czapula K; Rotkiewicz T; Otrocka-Domagała I; Gesek M; Śmiech A
Vet Res Commun; 2015 Mar; 39(1):7-17. PubMed ID: 25563490
[TBL] [Abstract][Full Text] [Related]
14. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
Wehrle-Martinez AS; Dittmer KE; Aberdein D; Thompson KG
Vet Pathol; 2016 Jul; 53(4):781-7. PubMed ID: 26926085
[TBL] [Abstract][Full Text] [Related]
15. Possible role of Snail expression as a prognostic factor in canine mammary neoplasia.
Im KS; Kim JH; Kim NH; Yu CH; Hur TY; Sur JH
J Comp Pathol; 2012; 147(2-3):121-8. PubMed ID: 22297072
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the Distribution Profiles of Circulating MicroRNAs by Asymmetrical Flow Field Flow Fractionation.
Flack K; Jimenez LA; Zhong W
Methods Mol Biol; 2017; 1509():161-168. PubMed ID: 27826926
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Kawaguchi T; Hirajima S; Ohashi T; Imamura T; Kiuchi J; Arita T; Konishi H; Shiozaki A; Moriumura R; Ikoma H; Okamoto K; Taniguchi H; Itoh Y; Otsuji E
Oncotarget; 2016 Aug; 7(33):53820-53836. PubMed ID: 27462777
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives.
Link A; Kupcinskas J
World J Gastroenterol; 2018 Aug; 24(30):3313-3329. PubMed ID: 30122873
[TBL] [Abstract][Full Text] [Related]
19. Candidate circulating microRNA biomarkers in dogs with chronic pancreatitis.
Armstrong SK; Hunter RW; Oosthyuzen W; Parys M; Gow AG; Schmitz SS; Dear JW; Mellanby RJ
J Vet Intern Med; 2024; 38(2):995-1004. PubMed ID: 38351718
[TBL] [Abstract][Full Text] [Related]
20. A Robust Protocol to Quantify Circulating Cancer Biomarker MicroRNAs.
Bell E; Watson HL; Bailey S; Murray MJ; Coleman N
Methods Mol Biol; 2017; 1580():265-279. PubMed ID: 28439839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
